title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"US Neurologists Optimistic Regarding the Huntington's Disease Treatment Pipeline, Emphasizing Halting Neurodegeneration as Leading Treatment Priority",20240103T144651,https://www.benzinga.com/pressreleases/24/01/g36470593/us-neurologists-optimistic-regarding-the-huntingtons-disease-treatment-pipeline-emphasizing-haltin,VCNX,0.04823,Neutral,0.057266
"Applied DNA Sciences  ( NASDAQ:APDN )  Downgraded by StockNews.com to ""Sell""",20230208T084249,https://www.defenseworld.net/2023/02/08/applied-dna-sciences-nasdaqapdn-downgraded-by-stocknews-com-to-sell.html,VCNX,0.084722,Neutral,0.060823
"Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday - ABVC BioPharma  ( NASDAQ:ABVC ) , Altimmune  ( NASDAQ:ALT ) ",20220926T074323,https://www.benzinga.com/news/22/09/29002223/why-nanovibronix-shares-surged-over-25-here-are-82-biggest-movers-from-friday,VCNX,0.044551,Neutral,0.0
"Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket - Enphase Energy  ( NASDAQ:ENPH ) , Youdao  ( NYSE:DAO ) ",20230208T121742,https://www.benzinga.com/news/23/02/30805823/why-sintx-technologies-shares-are-trading-lower-by-38-here-are-20-stocks-moving-premarket,VCNX,0.208166,Neutral,-0.036641
87 Biggest Movers From Yesterday,20220310T095725,https://www.benzinga.com/news/22/03/26075474/87-biggest-movers-from-yesterday,VCNX,0.046953,Neutral,0.001846
"VAALCO Energy  ( NYSE:EGY )  Lowered to ""Hold"" at StockNews.com",20230208T083445,https://www.defenseworld.net/2023/02/08/vaalco-energy-nyseegy-lowered-to-hold-at-stocknews-com.html,VCNX,0.082963,Neutral,0.024901
"Thor Industries, AutoNation And 3 Stocks To Watch Heading Into Monday - XIAO-I  ( NASDAQ:AIXI ) , AutoNation  ( NYSE:AN ) ",20230925T084125,https://www.benzinga.com/news/earnings/23/09/34852567/thor-industries-autonation-and-3-stocks-to-watch-heading-into-monday,VCNX,0.578355,Bearish,-0.420844
"Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte",20230918T210100,https://www.prnewswire.com/news-releases/head-and-neck-squamous-cell-carcinoma-market-to-witness-upsurge-in-growth-by-2032-assesses-delveinsight--key-companies-in-the-market---pfizer-merck-eisai-astrazeneca-innate-roche-glaxosmithkline-beigene-io-biotech-incyt-301930322.html,VCNX,0.023146,Neutral,0.04357
